Opus Point Partners Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Opus Point Partners Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-30,000	Closed	-$236K	–	62
2015 Q4	$236K	Sell	30,000 -15,300	-34%	-$132K	0.16%	55
2015 Q3	$383K	Sell	45,300 -34,700	-43%	-$320K	0.21%	47
2015 Q2	$876K	Buy	+80,000	New	+$1.03M	0.69%	39

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Opus Point Partners Management's INFI Position: Q1 2016 in Review

Opus Point Partners Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2016, closing a stake of 30,000 shares — an estimated $236K sold.

Opus Point Partners Management first reported a position in INFI in Q2 2015 and held it in 3 quarters. The position peaked at $876K in Q2 2015. 117 funds tracked by Wall St. Rank hold INFI as of Q1 2016.

Opus Point Partners Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Opus Point Partners Management sold 30,000 Infinity Pharmaceuticals, Inc. shares in Q1 2016, an estimated $236K.
Opus Point Partners Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2015 and held it in 3 quarters.
Opus Point Partners Management's Infinity Pharmaceuticals, Inc. position peaked at $876K in Q2 2015.
117 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2016.

Based on Opus Point Partners Management's 13F filing for Q1 2016, filed 13 May 2016.